Participants with T2D and overweight research hub

Efficacy and safety of once-weekly semaglutide s.c. 2.0 mg as add-on to dose-reduced insulin glargine vs titrated insuline glargine in participants with type 2 diabetes and overweight

This study is looking at how a weekly injection called semaglutide (Ozempic) works alongside a reduced dose of insulin glargine (Lantus) in people with type 2 diabetes who are also overweight. We want to see if this combination helps manage blood sugar better.